FDA Inspection
BASF SEBASF SE – FDA Inspection, Jul 13, 2018
Record Details
This FDA Inspection record concerns BASF SE, with an inspection on July 13, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 0fb45418-9d06-4ec4-8222-3bdb900249a7
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1061372
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of BASF SE
5| Date | Classification | Office | Project area |
|---|---|---|---|
| August 29, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 16, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 10, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 27, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 17, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for BASF SE
- FDA Inspection 1289396 - 2024-08-29
- FDA Inspection 1220597 - 2020-09-16
- FDA Inspection 989833 - 2016-03-10
- FDA Inspection 841539 - 2013-06-27
- FDA Inspection 659697 - 2010-03-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.